University of Rochester gets $4.5M From FDA to Study Clinical Pain Trials

The FDA will grant the University of Rochester Medical Center a $4.5 million grant over five years to study different approaches to improve methods used to evaluate and approve treatments for acute and chronic pain, according to a University news release.

Advertisement

Clinical trials of pain medication often produce less-than-ideal results because the control group, or patients receiving a placebo, often improve more than expected. A team of researchers will explore how the design of chronic and acute pain trials can be improved.

Related Articles on Pain Management:

Pieces of the Puzzle: Creating a Multidisciplinary Approach to Pain Management
Anesthesiologist Compensation and Reimbursement in 2011: 10 Recent Findings
Spine Pain Management Adds to Leadership Team

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.